NCT03664674: A trial that was reported late by Otonomy, Inc.
This trial has reported, although it was 302 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT03664674 |
|---|---|
| Title | A Prospective, Randomized, Double Blind, Placebo-controlled, Multicenter, Phase 3 Efficacy and Safety Study of OTO-104 Given as a Single Intratympanic Injection in Subjects With Unilateral Meniere's Disease |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Aug. 27, 2018 |
| Completion date | Dec. 22, 2020 |
| Required reporting date | Dec. 22, 2021, midnight |
| Actual reporting date | Oct. 20, 2022 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | 302 |